Research Area

Infectious Disease Research Services

Your Trusted Partner for Preclinical Infectious Disease Research

BIOQUAL provides preclinical infectious disease research services spanning viral, bacterial and parasitic pathogens. Our scientists combine in vivo models, in vitro assays, BSL-3 capabilities and custom model development to support vaccine, therapeutic and translational research programmes.

 

With decades of experience under our belt, our team is equipped to deliver a comprehensive suite of services, from therapeutic testing and vaccine research to developing custom assays for unique pathogen challenges. We combine scientific expertise with cutting-edge technology to support our clients’ diverse research needs, helping shape the future of therapeutics.

Integrated Infectious Disease Research Capabilities

BIOQUAL offers a full range of capabilities tailored to address the complex nature of viral, bacterial, and parasitic pathogens. Our services include:

Assay Development

With proven methodologies, we develop and optimize assays that ensure accurate, consistent results for a wide variety of targets.

Pathogen-Specific Studies​

Our team has extensive experience in working with high-priority pathogens such as HIV, influenza, SARS-CoV-2, malaria and many more, providing reliable insights for R&D and preclinical testing. Our service offerings are also continuously evolving to meet global health needs and emerging threats.

 

Study Types: Pathogenesis, Vaccine Testing, Therapeutics Testing, Dose-ranging Studies, Infusion Dosing, BSL-3 (Including Select Agent) and BSL-2-requiring Studies, PK/Safety Testing

Infectious Disease Animal Models

BIOQUAL offers an array of preclinical animal models, including specialized non-human primate models, to enable in-depth study of infection mechanisms and therapeutic efficacy testing.

Don’t see the assay or model you need from the lists below?

Contact us to discuss your unique requirements—our team is committed to developing tailored solutions to meet your specific research goals.

Respiratory Viruses
(SARS-CoV-2, SARS-CoV-1, RSV, Influenza)

Viral

Mosquito-borne Viruses (Zika, Chikungunya, Dengue, Mayaro)

Viral

Human Immunodeficiency Virus (HIV/SHIV/SIV)

Viral

Orthopox Virus

Viral

Herpes Simplex Virus (HSV)

Viral

Staphylococcus aureus

Bacteria

Clostridium difficile

Bacteria

Mycobacterium tuberculosis​

Bacteria

Malaria

Parasite

Viral Disease Research Services

Respiratory Viruses
(Influenza, RSV, SARS-CoV-1, SARS-CoV-2)

Animal Models
SARS-CoV-1: hACE2 Tg mice, hTMPRSS2 KI mice, rhesus macaques SARS-CoV-2: hACE2 Tg mice, Golden Syrian hamsters, cynomolgus macaques, African green monkeys, marmosets Influenza: BALB/c mice, ferrets, cynomolgus and rhesus macaques RSV: BALB/c mice, cynomolgus macaques, African green monkeys
In vitro Services

Sample processing
qRT-PCR, TCID50, and plaque assay viral load testing
Binding antibody ELISA, HAI, ELLA, MN, and neutralization assays
Flow-based characterization and functional assays of immune cell populations
Cytokine/chemokine detection and analysis using ELISpot, Luminex, and ELISA
Virus stock generation in cells and embryonated chicken eggs
Testing available for various influenza A and B virus strains available (including seasonal and avian strains)
Antiviral assays
Custom assay development

Mosquito-borne Viruses (Zika, Chikungunya, Dengue, Mayaro)

Animal Models

IFNAR-/- mice (AG129), BALB/c, C57BL/6 mice

Non-human primates (NHP) including African green monkeys, rhesus and cynomolgus macaques

In vitro Services

Sample processing

qRT-PCR and plaque assay for viral load testing

Binding antibody ELISA and neutralization assays such as PRNT

Flow-based characterization and functional assays

Cytokine analysis using ELISpot and Luminex

Human Immunodeficiency Virus (HIV/SHIV/SIV)

Animal Models

Non-human primates

HIV/humanized mouse models

In vitro Services

Virus stock generation
Sample processing
Flow-based characterization and functional assays
Cytokine analysis using ELISpot and Luminex
qRT -PCR and TCID50 viral load testing
P24 and binding antibody ELISA

Orthopox Virus

Animal Models

Mpox : CAST/EiJ mice, rhesus and cynomolgus macaques

Vaccinia, cowpox, mouse pox: BALB/c mice

In vitro Services

Viral stock generation
Sample processing
qRT -PCR, TCID50and plaque assay for viral load testing
Binding antibody ELISA and PRNT
Flow-based characterization and functional assays
Cytokine analysis using ELISpot and Luminex

Herpes Simplex Virus (HSV)

Animal Models

Guinea Pig

Mouse

Rabbit

In vitro Services

Viral stock generation
Sample processing
qRT -PCR and plaque assay for viral load testing

Preclinical Bacterial Research Services

Staphylococcus aureus

Animal Models

NHPs

Mice

In vitro Services

Stock generation
Sample processing
Bacterial enumeration
Serological Testing
Flow cytometry and Luminex

Clostridium difficile

Animal Models

Mice

In vitro Services

Stock generation
Sample processing
Bacterial enumeration
Serological Testing
Flow cytometry and Luminex

Mycobacterium tuberculosis (Coming Soon)

Animal Models

Coming Soon

In vitro Services

Coming Soon

Preclinical Parasite Research Services

Animal Models

BALB/c and CD1 mice

Rhesus macaque and squirrel monkeys

In vitro Services

Sample processing
Giemsa stained blood smears
Serological Testing

Advanced Laboratory Capabilities

BIOQUAL’s laboratories are designed to meet the highest safety and quality standards:

Biosafety Levels and Facilities


Our labs operate up to BSL-3 with select agent standards, ensuring the safe handling of highly infectious agents.

State-of-the-Art Technology

From immunoassays to advanced imaging, BIOQUAL’s technology stack supports complex research needs with precision.

Quality and Compliance

We are AAALAC-accredited and can run regulatory-compliant experiments for high-stakes preclinical studies and IND submissions.

Contact Us
Today!

Learn more about our services and how they can support your research. Reach out to us for a consultation and get started.